A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). [electronic resource]
Producer: 20100422Description: 163-74 p. digitalISSN:- 1555-2101
- Adolescent
- Adult
- Aged
- Antidepressive Agents -- adverse effects
- Antidepressive Agents, Second-Generation -- adverse effects
- Antimanic Agents -- adverse effects
- Bipolar Disorder -- drug therapy
- Dibenzothiazepines -- adverse effects
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Paroxetine -- adverse effects
- Placebos
- Psychiatric Status Rating Scales
- Quetiapine Fumarate
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.